Samsara Vision (SMSA.US) logged on NASDAQ tonight, offering between US $5 and US $7, issuing 4.2 million shares and raising US $25 million.
Founded in 2015, formerly known as VisionCare Inc., New Jersey, USA, Samsara Vision is a professional medical device company dedicated to bringing vision and freedom to patients with advanced retinal diseases and producing medical implants for retinal diseases such as AMD. The company's product line currently consists of two implantable miniature telescopes (IMT) and their Tsert delivery systems.
In the first nine months of 2021, it had revenue of $39000 and a net loss of $5.832 million.
Founded in 2015, formerly known as VisionCare Inc., New Jersey, USA, Samsara Vision is a professional medical device company dedicated to bringing vision and freedom to patients with advanced retinal diseases and producing medical implants for retinal diseases such as AMD. The company's product line currently consists of two implantable miniature telescopes (IMT) and their Tsert delivery systems.
In the first nine months of 2021, it had revenue of $39000 and a net loss of $5.832 million.